Showing results (121-130 of 205) with videos related to
Sort By:
Pageof 21
European Heart Journal. Cardiovascular Imaging|February 2, 2012
The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiographyJulia Grapsa, J Simon R Gibbs, Ines Zimbarra Cabrita, et al.Circulation. Cardiovascular Imaging|June 12, 2015
Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-UpJulia Grapsa, Maria Carmo Pereira Nunes, Timothy C Tan, et al.Pulmonary Circulation|January 23, 2015
Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factorsAthanasios Charalampopoulos, Luke S Howard, Ioanna Tzoulaki, et al.European Heart Journal. Imaging Methods and Practice|December 8, 2025
The Valvular Heart Disease in Women (VHD-W) Registry: a global initiative to address gender disparities in management and outcomesShehab Anwer, Pablo Perez-Lopez, Ali A Elzieny, et al.Journal of Cardiac Failure|June 5, 2021
Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart FailureLaura P Gelfman, Harriet Mather, Karen McKendrick, et al.Circulation. Heart Failure|September 3, 2020
Prognostic Awareness and Goals of Care Discussions Among Patients With Advanced Heart FailureLaura P Gelfman, Rebecca L Sudore, Harriet Mather, et al.European Heart Journal. Cardiovascular Imaging|September 5, 2014
Strain balance of papillary muscles as a prerequisite for successful mitral valve repair in patients with mitral valve prolapse due to fibroelastic deficiencyJulia Grapsa, Ines Zimbarra Cabrita, Gentjan Jakaj, et al.ESC Heart Failure|February 17, 2021
Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trialMark N Belkin, Francis J Alenghat, Stephanie A Besser, et al.Cardiovascular Drugs and Therapy|January 25, 2019
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?Carlos G Santos-Gallego, Alvaro Garcia-Ropero, Donna Mancini, et al.World Journal of Cardiology|January 8, 2020
Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directionsRafael Vidal-Perez, Charigan Abou Jokh Casas, Rosa Maria Agra-Bermejo, et al.Pageof 21